Obesity results from a prolonged imbalance between energy intake and expenditure, but reducing the disease to this thermodynamic equation ignores the biological mechanisms that lock in weight gain. Adipose tissue, hormonal signals, medication, circadian rhythm: the determinants interact through feedback loops that simple willpower cannot correct. This article details the less covered aspects by common popularization.
Adipose Tissue and Inflammatory Loops: Why Obesity Sustains Itself
Adipose tissue is not a passive reservoir. When it develops beyond a certain threshold, its structure changes: hypertrophied adipocytes secrete pro-inflammatory cytokines that disrupt leptin and insulin signaling. This chronic low-grade inflammation establishes hormonal resistance that prevents spontaneous return to a previous weight.
Inserm describes this alteration as a structural and functional change in adipose tissue, specifying that once established, obesity becomes biologically irreversible. This point is crucial: it distinguishes the disease from a simple transient weight excess and justifies medical management rather than an isolated restrictive diet.
The location of fat exacerbates the situation. Visceral adiposity, measurable by waist circumference, generates more metabolic disturbances than subcutaneous fat. An identical BMI can mask very different risk profiles depending on the distribution of adipose tissue, which relativizes the relevance of BMI as a unique indicator.
Medications and Weight Gain: An Underestimated Concrete Factor
Some treatments directly contribute to weight gain, a documented factor but rarely highlighted in public etiological assessments. The health sources consulted notably cite psychotropics and corticosteroids among the most affected pharmacological classes. To better understand the factors of obesity on Le Coin du Bien-être, this iatrogenic dimension deserves to be systematically explored during a medical assessment.
The mechanism varies depending on the molecule: increased appetite, modification of carbohydrate metabolism, water retention, or decreased resting energy expenditure. A patient on prolonged corticosteroid therapy may notice a redistribution of fat (Cushingoid face, truncal adiposity) without any change in their diet.
The clinical recommendation is clear: never modify a treatment on one’s own initiative. Reviewing the prescription with the treating physician allows for identifying substitutable molecules and quantifying their actual contribution to weight gain.
Sleep and Weight Regulation: Beyond the Number of Hours
Presenting sleep deprivation as a direct cause of obesity is an oversimplification. A systematic review dedicated to overweight adults concludes that the results on sleep duration are heterogeneous. However, some experimental studies suggest that sleep restriction reduces fat mass loss during a behavioral program, without necessarily affecting total weight loss.
The distinction between duration, quality, and satisfaction of sleep is therefore relevant. The French recommendations summarized by HAS advocate for investigating sleep disorders in the evaluation of obesity, alongside binge eating or nighttime eating. We consider these elements part of the diagnostic assessment, not just lifestyle hygiene.
- Sleep duration alone does not predict the risk of overweight: sleep fragmentation and the presence of obstructive apneas count for more.
- Sleep restriction increases ghrelin (orexigenic hormone) and decreases leptin (satiety hormone), creating a disproportionate hunger signal.
- The obstructive sleep apnea syndrome, common among obese patients, worsens insulin resistance and makes weight loss more difficult.
Eating Behaviors: Distinguishing Behavior from Disorder
Popular articles list unbalanced eating among the causes of obesity without distinguishing a modifiable behavior from a characterized disorder. Binge eating disorder affects a significant proportion of patients with severe obesity. It is distinguished from snacking by episodes of loss of control with rapid ingestion of large quantities, followed by psychological distress.
HAS recommends systematically screening for binge eating disorder and nighttime eating in the initial assessment. A restrictive diet prescribed to a patient suffering from undiagnosed binge eating generally worsens the disorder and promotes cycles of weight loss and regain.
We believe that this clinical distinction conditions therapeutic orientation: classic nutritional management on one side, cognitive-behavioral therapy or psychiatric follow-up on the other. Confusing them amounts to treating a symptom without addressing the mechanism.
Genetics and Epigenetics: What Genes Really Determine
The genetic component of obesity is documented by Inserm, which qualifies it as both a genetic and epigenetic cause. Monogenic forms (mutation of the leptin gene or its receptor, MC4R mutation) remain rare. The majority of cases involve polygenic susceptibility, where dozens of variants modestly increase risk.
Epigenetics modifies gene expression without altering the DNA sequence. The nutritional environment in utero, maternal stress, or exposure to certain endocrine disruptors can durably program the metabolism of the future adult. This mechanism partly explains why individuals exposed to the same dietary conditions develop very different weight trajectories.
- Monogenic forms justify genetic screening, especially in cases of early severe obesity in children.
- Polygenic susceptibility does not condemn one to obesity: it lowers the threshold at which an obesogenic environment triggers weight gain.
- Transmissible epigenetic modifications over one or two generations open a field of prenatal prevention still little exploited in clinical practice.
Obesity engages biological, pharmacological, and behavioral mechanisms that far exceed the framework of caloric imbalance. A rigorous etiological assessment, including sleep analysis, treatment review, and screening for eating disorders, remains the prerequisite for any sustainable therapeutic strategy.
